---
figid: PMC8167159__gr2
figtitle: Strategies to tackle RAS-mutated metastatic colorectal cancer
organisms:
- NA
pmcid: PMC8167159
filename: gr2.jpg
figlink: /pmc/articles/PMC8167159/figure/fig2/
number: F2
caption: 'Main therapeutic strategies targeting RAS-mutant metastatic colorectal cancer.Five
  therapeutic strategies targeting RAS-mutant metastatic colorectal cancer were identified
  and categorized by different pharmacodynamic interferences with the RAS signal:
  direct RAS targeting, targeting the MAPK pathway, harnessing RAS through immunotherapy
  combinations, RAS targeting through metabolic pathways, and other miscellaneous
  approaches. The main molecular targets are shown and grouped according to the most
  suitable anti-RAS therapeutic strategy. Created with BioRended.com.Bcl-XL, B-cell
  lymphoma-extra large; CDK, cyclin-dependent kinase; CTLA-4, cytotoxic T-lymphocyte-associated
  protein 4; DDR, DNA damage response and repair; EGFR, epidermal growth factor receptor;
  ERK, extracellular signal-regulated kinase; GF, growth factor; GDP, guanosine diphosphate;
  GTP, guanosine triphosphate; MAPK, mitogen-activated protein kinase; mCRC, metastatic
  colorectal cancer; MDM2, murine double minute 2; MGMT, O6-methylguanine-DNA methyl-transferase;
  mTOR, mammalian target of rapamycin; PARP, poly (ADP-ribose) polymerase; PD-1, programmed
  cell death protein 1; PD-L1, programmed death-ligand 1; PI3K, phosphatidylinositol
  3-kinase; PTEN, phosphatase and tensin homolog; RTK, receptor tyrosine kinase; SHP2,
  Src homology region 2 domain-containing phosphatase-2; SOS1, sevenless homologue
  1.'
papertitle: Strategies to tackle RAS-mutated metastatic colorectal cancer.
reftext: G. Patelli, et al. ESMO Open. 2021 Jun;6(3):100156.
year: '2021'
doi: 10.1016/j.esmoop.2021.100156
journal_title: ESMO Open
journal_nlm_ta: ESMO Open
publisher_name: Elsevier
keywords: RAS | KRAS | sotorasib | adagrasib | colorectal cancer
automl_pathway: 0.9589164
figid_alias: PMC8167159__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8167159__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8167159__gr2.html
  '@type': Dataset
  description: 'Main therapeutic strategies targeting RAS-mutant metastatic colorectal
    cancer.Five therapeutic strategies targeting RAS-mutant metastatic colorectal
    cancer were identified and categorized by different pharmacodynamic interferences
    with the RAS signal: direct RAS targeting, targeting the MAPK pathway, harnessing
    RAS through immunotherapy combinations, RAS targeting through metabolic pathways,
    and other miscellaneous approaches. The main molecular targets are shown and grouped
    according to the most suitable anti-RAS therapeutic strategy. Created with BioRended.com.Bcl-XL,
    B-cell lymphoma-extra large; CDK, cyclin-dependent kinase; CTLA-4, cytotoxic T-lymphocyte-associated
    protein 4; DDR, DNA damage response and repair; EGFR, epidermal growth factor
    receptor; ERK, extracellular signal-regulated kinase; GF, growth factor; GDP,
    guanosine diphosphate; GTP, guanosine triphosphate; MAPK, mitogen-activated protein
    kinase; mCRC, metastatic colorectal cancer; MDM2, murine double minute 2; MGMT,
    O6-methylguanine-DNA methyl-transferase; mTOR, mammalian target of rapamycin;
    PARP, poly (ADP-ribose) polymerase; PD-1, programmed cell death protein 1; PD-L1,
    programmed death-ligand 1; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase
    and tensin homolog; RTK, receptor tyrosine kinase; SHP2, Src homology region 2
    domain-containing phosphatase-2; SOS1, sevenless homologue 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - MKP-4
  - p38b
  - rl
  - Fak
  - Pten
  - Tie
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - p53
  - betaTub60D
  - hth
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - Egfr
  - csw
  - Cdk4
  - CycD
  - Ddr
  - Parp
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - KRAS
  - HRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTK2
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - MDM2
  - DESI1
  - SLC35G1
  - TP53
  - TP63
  - TP73
  - MTG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - EGF
  - EGFR
  - PTPN11
  - CDK6
  - CDK4
  - CCND1
  - CCND2
  - CCND3
  - TNFRSF9
  - CTLA4
  - CD47
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - DDR1
  - DDR2
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
---
